Q3 2025 Holdings
Filed 2025-11-14 | 12 holdings | $258.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| CG Oncology, Inc.(CGON) | COM | 156944100 | $89.5M | 2,221,474 | 34.6% |
| Rapt Therapeutics, Inc.(RAPT) | COM | 75382E208 | $40.3M | 1,562,500 | 15.6% |
| Centessa Pharmaceuticals plc(CNTA) | SPONSORED ADS | 152309100 | $31.9M | 1,314,019 | 12.3% |
| Verastem, Inc.(VSTM) | COM | 92337C203 | $23.1M | 2,615,120 | 8.9% |
| Alumis Inc.(ALMS) | COM | 022307102 | $16.9M | 4,247,670 | 6.5% |
| Denali Therapeutics Inc.(DNLI) | COM | 24823R105 | $14.5M | 1,000,000 | 5.6% |
| Corvus Pharmaceuticals, Inc.(CRVS) | COM | 221015100 | $12.8M | 1,731,233 | 4.9% |
| Akero Therapeutics, Inc.(AKRO) | COM | 00973Y108 | $11.6M | 244,900 | 4.5% |
| Kymera Therapeutics, Inc.(KYMR) | COM | 501575104 | $8.3M | 146,332 | 3.2% |
| Hinge Health, Inc.(HNGE) | CL A | 433313103 | $6.6M | 135,000 | 2.6% |
| Avidity Biosciences, Inc.(RNA) | COM | 05370A108 | $1.7M | 40,000 | 0.7% |
| Casi Pharmaceuticals, Inc.(CASIF) | ORD SHS | G1933S101 | $1.6M | 979,956 | 0.6% |